deCODE Genetics ehf.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 11151
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 2445
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS147
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2003/0157,599 Gene for peripheral arterial occlusive diseaseJan 30, 02Aug 21, 03[C07H, C12Q, C12P, C12N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9617597 Genetic susceptibility variants associated with cardiovascular diseaseFeb 21, 08Apr 11, 17[C07H, C12Q]
8951735 Genetic variants for breast cancer risk assessmentJul 03, 09Feb 10, 15[C12Q]
8883833 Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersNov 20, 08Nov 11, 14[A61K, C07D]
8877816 4-(or 5-) substituted catechol derivativesNov 20, 08Nov 04, 14[A61K, C07D, C07C, A61P]
8865400 Genetic variants contributing to risk of prostate cancerFeb 07, 08Oct 21, 14[C07H, C12Q, C12P]
8828657 Susceptibility variants for lung cancerFeb 16, 09Sep 09, 14[C12Q, G01N]
8808985 Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysmApr 01, 09Aug 19, 14[C12P]
8795963 Genetic markers for risk management of atrial fibrillation and strokeMar 30, 10Aug 05, 14[C12Q, C12P]
8796182 Genetic markers associated with risk of diabetes mellitusJul 09, 10Aug 05, 14[C12Q, G06F, C40B]
8791267 Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disordersMar 26, 12Jul 29, 14[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0191,134 Sequence Variants Associated with Prostate Specific Antigen LevelsAbandonedAug 08, 16Jul 06, 17[C12Q, G01N, A61N]
2014/0329,719 GENETIC VARIANTS FOR PREDICTING RISK OF BREAST CANCERAbandonedJun 14, 12Nov 06, 14[C12Q, G06F]
2014/0301,999 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERSAbandonedJun 23, 14Oct 09, 14[A61K, C07D, C07C]
2014/0275,553 SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERSAbandonedMay 28, 14Sep 18, 14[C07D]
2014/0248,615 GENETIC VARIANTS ON CHR 11Q AND 6Q AS MARKERS FOR PROSTATE AND COLORECTAL CANCER PREDISPOSITIONAbandonedMar 06, 14Sep 04, 14[C12Q, G06F]
2014/0227,693 GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND STROKEAbandonedJan 13, 14Aug 14, 14[C12Q, G06F]
2014/0179,546 GENETIC VARIANTS ON CHR 5P12 AND 10Q26 AS MARKERS FOR USE IN BREAST CANCER RISK ASSESSMENT, DIAGNOSIS, PROGNOSIS AND TREATMENTAbandonedOct 09, 13Jun 26, 14[C12Q]
2014/0087,961 GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCERAbandonedMar 16, 12Mar 27, 14[C12Q]
2014/0080,727 VARIANTS PREDICTIVE OF RISK OF GOUTAbandonedFeb 09, 12Mar 20, 14[C12Q]
2013/0338,012 GENETIC RISK FACTORS OF SICK SINUS SYNDROMEAbandonedNov 17, 11Dec 19, 13[C12Q]
8598359 Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammationExpiredJun 11, 08Dec 03, 13[A61K, C07D]
8580501 Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatmentExpiredMay 21, 08Nov 12, 13[C07H, C12Q]
2013/0296,175 Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and TreatmentAbandonedJan 12, 12Nov 07, 13[C12Q, G01N, G06F]
2013/0273,543 GENETIC VARIANTS USEFUL FOR RISK ASSESSMENT OF THYROID CANCERAbandonedDec 20, 11Oct 17, 13[C12Q, G06F]
2013/0253,847 GENETIC VARIANTS AS MARKERS FOR USE IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF EOSINOPHILIA, ASTHMA, AND MYOCARDIAL INFARCTIONAbandonedDec 20, 12Sep 26, 13[G06F]
2013/0224,739 GENETIC MARKERS FOR RISK MANAGEMENT OF VASCULAR DISEASEAbandonedJun 22, 11Aug 29, 13[C12Q]
2012/0264,636 GENETIC VARIANTS INDICATIVE OF VASCULAR CONDITIONSAbandonedOct 07, 10Oct 18, 12[C12Q, G01N, G06F, C40B]
2012/0207,729 SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERSAbandonedApr 24, 12Aug 16, 12[A61K, C07D, A61P]
2012/0208,709 GENETIC SUSCEPTIBILITY VARIANTS ASSOCIATED WITH CARDIOVASCULAR DISEASEAbandonedApr 19, 12Aug 16, 12[C12Q, C40B]
2012/0149,016 Genetic Variants in the TCF7L2 Gene as Diagnostic Markers for Risk of Type 2 Diabetes MellitusAbandonedNov 11, 11Jun 14, 12[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.